FIRST MANHATTAN CO. LLC. Q3 2025 Filing

Filed November 14, 2025

Portfolio Value

$37.9B

Holdings

714

Report Date

Q3 2025

Filing Type

13F-HR

All Holdings (714 positions)

#	Stock	Shares	Value	% Portfolio	Type
701	OGNORGANON & CO	10,438	$111.5M	0.29%
702	TSHATAYSHA GENE THERAPIES INC	28,500	$93.2M	0.25%
703	CLSDQCLEARSIDE BIOMEDICAL INC	22,846	$90.7M	0.24%
704	OPKOPKO HEALTH INC	51,750	$80.2M	0.21%
705	VLNVALENS SEMICONDUCTOR LTD	43,458	$77.8M	0.21%
706	PTENPATTERSON-UTI ENERGY INC	14,041	$72.7M	0.19%
707	KLTRKALTURA INC	50,000	$72.0M	0.19%
708	I9DNARBUTUS BIOPHARMA CORP	14,000	$63.6M	0.17%
709	ZVIAZEVIA PBC	22,000	$59.8M	0.16%
710	DCFEURMOGO INC	26,400	$48.8M	0.13%
711	CALCCALCIMEDICA INC	13,226	$40.7M	0.11%
712	OVIDOVID THERAPEUTICS INC	26,000	$33.8M	0.09%
713	GROVGROVE COLLABORATIVE HOLD INC	11,662	$17.5M	0.05%
714	PDSBPDS BIOTECHNOLOGY CORP	15,000	$15.2M	0.04%

PreviousPage 8 of 8